Quant Consumption Fund
Direct · GrowthAI Summary
Quant Consumption Fund has delivered a 1Y SIP XIRR of -2.36%, significantly lagging the category average of 10.72%. Over longer horizons, the fund's lump-sum CAGR of 0.31% (3Y) trails the NIFTY 50's 1.19%, with negative alpha of -1.89% at 3Y and -1.62% at 5Y. The 1Y picture is more encouraging, with the fund's 0.69% CAGR beating the benchmark's -10.57% and generating a strong 8.99% alpha.
The fund exhibits a low beta of 0.81-0.87 versus the NIFTY 50, with downside capture of 78-80% indicating it falls less than the market. However, the Calmar Ratio of -0.1861 (1Y) reflects negative risk-adjusted returns, and the maximum drawdown duration of 549 days with no recovery suggests a prolonged drawdown period. The single drawdown event exceeding 10% indicates occasional sharp corrections despite generally lower volatility.
The portfolio is highly concentrated with only 15 holdings, and the top 10 account for roughly 79% of NAV. Capital Markets exposure is the largest sector at 19.2%, followed by Pharmaceuticals at 16.9%, while holdings like ICICI Prudential AMC (10.44%) and LG Electronics India (9.33%) represent significant single-stock bets. The fund's interpretation of 'consumption' is broad, including capital markets, pharma, telecom, and petroleum names, which dilutes the thematic purity.
The fund's -2.36% 1Y SIP XIRR is roughly 13 percentage points below the category average of 10.72%, placing it in the bottom tier of sectoral/thematic peers. Calendar year returns show inconsistency, swinging from 6.56% in 2024 to -7.58% in 2025 and back to 2.27% in 2026. Long-term alpha remains negative across 3Y to 15Y windows, indicating persistent underperformance versus the benchmark.
This fund suits only aggressive investors with high risk tolerance who want a tactical, satellite allocation in a consumption-linked theme, and who can tolerate extended drawdowns like the current 549-day unrecovered one. A time horizon of at least 5-7 years is advisable given the volatility and cyclicality of the sector. Investors seeking steady core portfolio returns should look elsewhere given the weak category-relative performance.
- Strong 1Y alpha of 8.99% versus the NIFTY 50, with the fund's 0.69% CAGR beating the benchmark's -10.57% in a weak market
- Low beta of 0.81-0.87 and downside capture near 78-80%, offering better downside protection than the index
- Low expense ratio of 0.81% for a Direct plan, keeping costs competitive
- 1Y SIP XIRR of -2.36% trails the category average of 10.72% by a wide margin, signaling weak peer-relative performance
- Highly concentrated portfolio of only 15 holdings with the top three stocks near 9-10% each, amplifying single-stock risk
- Negative alpha across 3Y to 15Y windows and a 549-day unrecovered maximum drawdown indicate persistent long-term underperformance
Generated on 13-10-2026, 3:08 AM. Verify before investing.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹11.70 L | -4.4% | -30.9% | 21.1% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | -4.4% | 14.3% | 10.7% | -18.7% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | -5.6% | -6.6% | -17.9% | 7.8% | -2.03 | -0.90 | 24% | — | — |
Calmar Ratio by Duration
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +7.10 | 0.84 | 87.0% | 76.4% | 0.1% | -9.5% |
| 3 Years | -2.56 | 0.80 | 77.1% | 79.3% | 0.4% | 2.1% |
| 5 Years | -2.05 | 0.80 | 77.1% | 79.3% | 0.3% | 1.3% |
| 7 Years | -1.83 | 0.80 | 77.1% | 79.3% | 0.2% | 0.9% |
| 10 Years | -1.66 | 0.80 | 77.1% | 79.3% | 0.1% | 0.6% |
| 12 Years | -1.59 | 0.80 | 77.1% | 79.3% | 0.1% | 0.5% |
| 15 Years | -1.54 | 0.80 | 77.1% | 79.3% | 0.1% | 0.4% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | ICICI Prudential AMC Ltd | 10.44% |
| 2 | LG Electronics India Limited | 9.33% |
| 3 | Capri Global Capital Limited | 9.03% |
| 4 | Aurobindo Pharma Limited | 8.94% |
| 5 | Nippon Life India Asset Management Ltd | 8.77% |
| 6 | Reliance Industries Ltd. | 8.62% |
| 7 | Ventive Hospitality Limited | 8.03% |
| 8 | Zydus Lifesciences Limited | 7.16% |
| 9 | Bharti Airtel Limited | 4.57% |
| 10 | Colgate-Palmolive (India) Ltd | 4.54% |